AIM ImmunoTech
34 hedge funds and large institutions have $1.97M invested in AIM ImmunoTech in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
13% more funds holding
Funds holding: 30 → 34 (+4)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
35% less capital invested
Capital invested by funds: $3.01M → $1.97M (-$1.04M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$31.1K |
| 2 |
VF
Virtu Financial
New York
|
+$17.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.2K |
| 4 |
Renaissance Technologies
New York
|
+$8.32K |
| 5 |
HF
HRT Financial
New York
|
+$6.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$113K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$36.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$18.1K |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
-$5.55K |
| 5 |
Jane Street
New York
|
-$5.24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HI
26
Hoey Investments
Coatesville,
Pennsylvania
| $455 | – | – | – |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $420 | -$2.4K | -39 | -81% |
|
28
Wells Fargo
San Francisco,
California
| $330 | – | – | – |
|
|
AF
29
Advisornet Financial
Minnetonka,
Minnesota
| $228 | +$308 | +5 | New |
|
|
IWP
30
IAG Wealth Partners
Waukesha,
Wisconsin
| $218 | +$308 | +5 | New |
|
|
TWC
31
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $105 | – | – | – |
|
32
JP Morgan Chase
New York
| $27 | +$62 | +1 | New |
|
|
HNB
33
Huntington National Bank
Columbus,
Ohio
| $26 | – | – | – |
|
34
Qube Research & Technologies (QRT)
London,
United Kingdom
| $1 | – | – | – |
|
|
35
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$36.6K | -547 | Closed |
|
36
Bank of America
Charlotte,
North Carolina
| – | -$3.08K | -50 | Closed |
|
|
CFGS
37
Concourse Financial Group Securities
Birmingham,
Alabama
| – | -$308 | -5 | Closed |
|
AIM Hedge Fund Activity: Q3 2023 in Review
34 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2023, worth a combined $1.97M — down 35% from $3.01M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new AIM positions and 3 closed out — a net gain of 4 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Two Sigma Securities, adding an estimated $31.1K. The largest seller was Morgan Stanley, cutting an estimated $113K.
- 34 institutional investors held AIM ImmunoTech (AIM) as of Q3 2023, up from 30 in Q2 2023.
- Funds reported $1.97M of AIM ImmunoTech stock for Q3 2023, down 35% quarter-over-quarter.
- 7 funds opened new AIM ImmunoTech positions in Q3 2023 and 3 closed out, a net change of +4 holders.
- The largest AIM ImmunoTech buyer in Q3 2023 was Two Sigma Securities, an estimated $31.1K added.
- The largest AIM ImmunoTech seller in Q3 2023 was Morgan Stanley, an estimated $113K sold.
Based on aggregated 13F filings for Q3 2023.